Results for:(36 found)
Jan 3, 2013 2:17PM on Top StocksBy Minyanville.com

Shares are dropping after the big biotech says it's scrapping an R&D program for ALS. But a new pill for multiple sclerosis continues to be the major catalyst for this stock.

Tags: BIIBNVS
Dec 27, 2012 11:51AM on Top StocksBy Minyanville.com

Biogen Idec, Pfizer, Bristol-Myers and Celgene are among companies awaiting US approval of key treatments.

Dec 27, 2012 9:03AM on Top StocksBy Stock Traders Daily

The market is growing and the opportunities are there, but so are the risks.

Dec 14, 2012 1:45PM on Top StocksBy Jim J. Jubak

The company's forecast for its pipeline has doubled in the last year.

Tags: BMYNVS
Dec 13, 2012 1:12PM on Top StocksBy InvestorPlace

Some pharma stocks could get a shot in the arm as CDC issues early warning.

Dec 12, 2012 12:21PM on Top StocksBy MSN Money Partner

Teva is downgraded to 'market perform,' and Under Armour is initiated with an 'underweight.'

Dec 10, 2012 1:36PM on Top StocksBy Benzinga

10 of the Continent's best exchange-traded funds for the new year.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More